News
March 26, 2018

New study to measure impact of sleep tracker data on patient-provider communication

INDIANAPOLIS – According to a survey by Pew Research, nearly two-thirds of adults in the U.S. collect their own data on at least one health indicator through the use of tracking devices and apps, and it is estimated by industry analysts that over 30 million Americans have access to their sleep data. While many patients are treated for sleep disturbances in primary care practices, much of this tracked sleep data never reaches the health care providers, and the impact on care is largely unknown. A new exploratory study from the National Sleep Foundation and Merck, in collaboration with the Regenstrief Institute examines how use of sleep tracker data might improve patient-provider communication, and ultimately, patient satisfaction with that communication. The prospective, randomized, parallel group study is funded by Merck and the National Sleep Foundation, and will utilize Fitbit® devices.

“The primary objective of the study is to determine if a program using a commercially available sleep tracker can be used to improve physician-patient dialogue regarding sleep,” Babar A. Khan, MD, of the Indiana University Center for Aging Research at Regenstrief Institute and the Indiana University School of Medicine, who will lead the project.

Research participants – 210 patients with insomnia and their Indianapolis-based primary care providers – will use the National Sleep Foundation’s SleepLife® program to provide a continuous flow of real time sleep information over the course of the study. The tool will combine sleep data from Fitbit Charge 2® devices into SleepLife’s secure interface accessible to patients and physicians. Researchers will then measure results through objective data collected through the tracker, and subjective data via questionnaires.

“This study will provide insight into the utility of consumer sleep monitoring devices for the incorporation of sleep as a vital sign in the primary care setting.  Delivering relevant sleep information to providers in a streamlined fashion is paramount to encouraging communication about sleep and helping people get a better night’s sleep sooner,” said Michael Paskow, MPH, Director of Scientific Affairs & Research at the National Sleep Foundation.

“Wearable devices have revolutionized our ability to collect and monitor health data on a much larger scale and the ability to provide sleep data on a daily basis can help increase our understanding of real world sleep habits and how to improve them,” said Dr. Conor Heneghan, lead sleep research scientist at Fitbit.

The results of this study are anticipated to serve as a model for further research exploring a new paradigm for patient-provider communication, and the integration of objective, patient-generated data through applications and wearable technology into primary care.

About the National Sleep Foundation:

The National Sleep Foundation (NSF) is dedicated to improving health and well-being through sleep education and advocacy. Founded in 1990, the NSF is committed to advancing excellence in sleep health theory, research and practice.

Sleepfoundation.org  | Sleep.org | SleepHealthJournal.org

 

About Regenstrief Institute:
Established in 1969 by industrial visionary and philanthropist Sam Regenstrief, the Regenstrief Institute is an Indianapolis-based organization dedicated to improving local, national, and global health and health care through innovation and research in biomedical informatics, health services, and aging. Regenstrief Institute is a faculty-led support organization of the Indiana University School of Medicine, and has several regional partners which include IU Health, Eskenazi Health, and the Richard L. Roudebush VA Medical Center.

Regenstrief.org

 

Media contacts:
National Sleep Foundation:
Tim Colbert
(412) 548-1842
tim@shiftcollaborative.com

 

Regenstrief Institute:
Lisa Welch
317-274-9234
llwelch@regenstrief.org

Related News

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study

Joshua Vest, PhD, MPH

Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is

AMIA honors Regenstrief researcher with leadership award

Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, was awarded a 2024 leadership award by the American Medical